Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement

被引:217
作者
Deverka, Patricia A. [1 ]
Lavallee, Danielle C. [1 ]
Desai, Priyanka J. [1 ]
Esmail, Laura C. [1 ]
Ramsey, Scott D. [2 ]
Veenstra, David L. [3 ]
Tunis, Sean R. [1 ]
机构
[1] Ctr Med Technol Policy, Baltimore, MD 21202 USA
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, North Seattle, WA 98109 USA
[3] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
关键词
cancer genomics; comparative effectiveness research; consumer participation; deliberative methods; public participation; stakeholder engagement; stakeholders; HEALTH TECHNOLOGY-ASSESSMENT; PUBLIC-PARTICIPATION; CONSUMER INVOLVEMENT; CONCEPTUAL-FRAMEWORK; POLICY; DELIBERATION; PRINCIPLES; MANAGEMENT; DECISIONS; SUCCESS;
D O I
10.2217/CER.12.7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Aims: Stakeholder engagement is fundamental to comparative effectiveness research (CER), but lacks consistent terminology. This paper aims to define stakeholder engagement and present a conceptual model for involving stakeholders in CER. Materials & methods: The definitions and model were developed from a literature search, expert input and experience with the Center for Comparative Effectiveness Research in Cancer Genomics, a proof-of-concept platform for stakeholder involvement in priority setting and CER study design. Results: Definitions for stakeholder and stakeholder engagement reflect the target constituencies and their role in CER. The 'analytic-deliberative' conceptual model for stakeholder engagement illustrates the inputs, methods and outputs relevant to CER. The model differentiates methods at each stage of the project; depicts the relationship between components; and identifies outcome measures for evaluation of the process. Conclusion: While the definitions and model require testing before being broadly adopted, they are an important foundational step and will be useful for investigators, funders and stakeholder groups interested in contributing to CER.
引用
收藏
页码:181 / 194
页数:14
相关论文
共 60 条
[1]   Deliberations about deliberative methods: issues in the design and evaluation of public participation processes [J].
Abelson, J ;
Forest, PG ;
Eyles, J ;
Smith, P ;
Martin, E ;
Gauvin, FP .
SOCIAL SCIENCE & MEDICINE, 2003, 57 (02) :239-251
[2]   Bringing 'the public' into health technology assessment and coverage policy decisions: From principles to practice [J].
Abelson, Julia ;
Giacomini, Mita ;
Lehoux, Pascale ;
Gauvin, Francois-Pieffe .
HEALTH POLICY, 2007, 82 (01) :37-50
[3]  
Amaeshi K. M., 2006, Corporate Social Responsibility and Environmental Management, V13, P245, DOI 10.1002/csr.108
[4]  
[Anonymous], 1998, DELIBERATIVE DEMOCRA
[5]  
[Anonymous], 1996, Understanding Risk: Informing Decisions in a Democratic Society
[6]  
[Anonymous], 2010, NATL CANC CLIN TRIAL
[7]  
Apostolakis GE, 1998, RISK ANAL, V18, P621, DOI 10.1023/B:RIAN.0000005936.45310.22
[8]   Can the impact of public involvement on research be evaluated? A mixed methods study [J].
Barber, Rosemary ;
Boote, Jonathan D. ;
Parry, Glenys D. ;
Cooper, Cindy L. ;
Yeeles, Philippa ;
Cook, Sarah .
HEALTH EXPECTATIONS, 2012, 15 (03) :229-241
[9]  
Beierle TC, 2000, J POLICY ANAL MANAG, V19, P587, DOI 10.1002/1520-6688(200023)19:4<587::AID-PAM4>3.0.CO
[10]  
2-Q